A Case of Hepatocellular Carcinoma with Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy after Sorafenib Failure
Journal of Liver Cancer
;
: 72-76, 2017.
Article
in Korean
| WPRIM
| ID: wpr-156766
ABSTRACT
Hepatocellular carcinoma (HCC) is the 2nd most common cause of cancer related death in Korea and well-known malignancy with poor prognosis. Sorafenib is the first-line molecular targeted agent in patients with extra-hepatic spread of HCC. However, complete response is extremely rare in patients treated with sorafenib and the disease control rate is only 43%. We report a 53-year-old man with advanced HCC with pulmonary metastasis who showed complete response by cytotoxic chemotherapy with doxorubicin and cisplatin with relatively tolerable adverse effects after failure of treatment with sorafenib.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Doxorubicin
/
Cisplatin
/
Carcinoma, Hepatocellular
/
Drug Therapy
/
Korea
/
Neoplasm Metastasis
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Journal of Liver Cancer
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS